Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122623) titled 'Effectiveness and safety of IV terlipressin as an add-on treatment for persistent pulmonary hypertension of the newborn' on April 15.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: West China Second University Hospital of Sichuan University (WCSUH- SCU)
Condition:
Persistent pulmonary hypertension of the newborn
Intervention:
Control group: iNO:inhaled nitric oxide
Recruitment Status: Recruiting
Phase: 4
Date of First Enrollment: 2026-04-15
Target Sample Size: Control group: iNO:109;Intervention group: iNO+TP:109;
Countries of Recruitment:
China
To know more, visit http...